Purchase Agreements in the Pharmaceuticals Industry

1,731 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (5 contracts)
60 DEGREES PHARMACEUTICALS, INC. (20)
Acacia Diversified Holdings, Inc. (6)
Acasti Pharma Inc. (1)
Accelerated Pharma, Inc. (11)
ACELRX PHARMACEUTICALS INC (13)
Acer Therapeutics Inc. (10)
Aclaris Therapeutics, Inc. (6)
Acreage Holdings, Inc. (1)
ACURA PHARMACEUTICALS, INC (1)
Adamis Pharmaceuticals Corp (18)
ADIAL PHARMACEUTICALS, INC. (13)
Aegerion Pharmaceuticals, Inc. (1)
AEOLUS PHARMACEUTICALS, INC. (8)
Aerpio Pharmaceuticals, Inc. (5)
AGILE THERAPEUTICS INC (6)
Akers Biosciences, Inc. (11)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (6)
Alexza Pharmaceuticals Inc. (2)
ALIMERA SCIENCES INC (9)
Allergan, plc (5)
ALSERES PHARMACEUTICALS INC (14)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (3)
Amneal Pharmaceuticals, Inc. (4)
Amphastar Pharma (3)
Ampio Pharmaceuticals, Inc. (10)
Amylyx Pharmaceuticals, Inc. (1)
Anebulo Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (1)
ANGIOTECH PHARMACEUTICALS INC (1)
ANI Pharma Inc (12)
Anthera Pharmaceuticals Inc (5)
APP Pharmaceuticals, Inc. (2)
Applied BioSciences Corp. (2)
APRICUS BIOSCIENCES, INC. (28)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (7)
Aralez Pharmaceuticals Inc. (22)
Arog Pharmaceuticals, Inc. (1)
ARTELO BIOSCIENCES, INC. (2)
Artemis Therapeutics, Inc. (6)
ARVINAS, INC. (1)
Assertio Holdings, Inc. (3)
Assertio Therapeutics, Inc (10)
Astex Pharmaceuticals, Inc (4)
AVADEL PHARMACEUTICALS PLC (5)
AVALON PHARMACEUTICALS INC (4)
AVANIR PHARMACEUTICALS, INC. (1)
AVENUE THERAPEUTICS, INC. (4)
AXIM BIOTECHNOLOGIES, INC. (6)
Axsome Therapeutics, Inc. (2)
AYTU BIOSCIENCE, INC (15)
BARR PHARMACEUTICALS INC (2)
Barrel Energy Inc. (1)
Baudax Bio, Inc. (12)
Bausch Health Companies Inc. (6)
Bespoke Extracts, Inc. (19)
Big Rock Partners Acquisition Corp. (11)
BIODELIVERY SCIENCES INTERNATIONAL INC (11)
Biofrontera Inc. (7)
Biohaven Ltd. (1)
BioPharmX Corp (10)
Biostar Pharmaceuticals, Inc. (2)
Blue Water Acquisition Corp. (2)
BODY & MIND INC. (13)
Boston Therapeutics, Inc. (12)
BRADLEY PHARMACEUTICALS INC (1)
Bright Green Corp (2)
Bristol-Myers Squibb (1)
CADENCE PHARMACEUTICALS INC (1)
CALLISTO PHARMACEUTICALS INC (3)
Canbiola, Inc. (18)
Cancer Prevention Pharmaceuticals, Inc. (1)
Cannabics Pharmaceuticals Inc. (4)
CANNAPHARMARX, INC. (11)
CANNAPOWDER, INC. (1)
Canopy Growth Corp (1)
Cantabio Pharmaceuticals Inc. (4)
Cara Therapeutics, Inc. (3)
CARDAX, INC. (5)
CASSAVA SCIENCES INC (4)
Catalent Inc (1)
Celator Pharmaceuticals Inc (1)
CELGENE CORP (1)
Cerecor Inc. (14)
CHINA PHARMA HOLDINGS, INC. (3)
Cingulate Inc. (8)
Citius Pharmaceuticals, Inc. (11)
Clearside Biomedical, Inc. (3)
CLS Holdings USA, Inc. (16)
CNS Pharmaceuticals, Inc. (12)
Cocrystal Pharma, Inc. (22)
COGNITION THERAPEUTICS INC (1)
COLLAGENEX PHARMACEUTICALS INC (1)
COLLEGIUM PHARMACEUTICAL, INC (1)
Columbia Care Inc. (6)
Context Therapeutics Inc. (4)
ContraVir Pharmaceuticals, Inc. (9)
Corcept Therapeutics Incorporated (3)
CorMedix Inc. (8)
COSMO VENTURES INC (6)
Cronos Group Inc. (1)
CUBIST PHARMACEUTICALS INC (1)
CUMBERLAND PHARMACEUTICALS INC (3)
Cure Pharmaceutical Holding Corp. (4)
Dermata Therapeutics, Inc. (5)
DURECT CORP (5)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (2)
Elanco Animal Health Inc (2)
ELITE PHARMACEUTICALS INC (13)
Eloxx Pharmaceuticals, Inc. (6)
ENCYSIVE PHARMACEUTICALS INC (2)
Endexx Corp (2)
Endo International plc (5)
Endo Pharmaceuticals Solutions Inc. (3)
EPIX Pharmaceuticals, Inc. (2)
Eton Pharmaceuticals, Inc. (8)
Evofem Biosciences, Inc. (29)
Evoke Pharma Inc (5)
Exactus, Inc. (10)
EYEGATE PHARMACEUTICALS INC (11)
EYENOVIA, INC. (10)
EyePoint Pharmaceuticals, Inc. (3)
Foamix Pharmaceuticals Ltd. (1)
FRONTIER OILFIELD SERVICES INC (1)
Fulcrum Therapeutics, Inc. (1)
Furiex Pharmaceuticals, Inc. (1)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (8)
GRAYBUG VISION, INC. (2)
GREEN HYGIENICS HOLDINGS INC. (6)
GridIron BioNutrients, Inc. (9)
GUILFORD PHARMACEUTICALS INC (1)
HARROW HEALTH, INC. (17)
Haymaker Acquisition Corp. III (3)
Horizon Pharma plc (4)
Hoth Therapeutics, Inc. (9)
IMAGING3 INC (1)
IMARA Inc. (3)
INNOVATE BIOPHARMACEUTICALS, INC. (9)
Innoviva, Inc. (2)
IntelGenx Technologies Corp. (10)
Intersect ENT, Inc. (1)
ISTA PHARMACEUTICALS INC (4)
Item 9 Labs Corp. (5)
Iterum Therapeutics plc (10)
Jaguar Health, Inc. (27)
Jazz Pharmaceuticals plc (5)
Jiangbo Pharmaceuticals, Inc. (2)
Journey Medical Corp (6)
JUNIPER PHARMACEUTICALS INC (7)
Jushi Holdings Inc. (1)
Kala Pharmaceuticals, Inc. (6)
Kannalife Inc (5)
Kedem Pharmaceuticals Inc. (1)
KEMPHARM, INC (5)
KING PHARMACEUTICALS INC (3)
KOS PHARMACEUTICALS INC (1)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (1)
Lev Pharmaceuticals Inc (3)
Level Brands, Inc. (3)
Lexaria Bioscience Corp. (14)
LIPELLA PHARMACEUTICALS INC (2)
Lipocine Inc. (3)
Liquidia Corp (1)
Longboard Pharmaceuticals, Inc. (1)
Lowell Farms Inc. (2)
Luckwel Pharmaceuticals Inc. (1)
Lyra Therapeutics, Inc. (2)
Mallinckrodt (7)
Marijuana Co of America, Inc. (2)
MARINUS PHARMACEUTICALS INC (2)
MedGen, Inc. (1)
Medicine Man Technologies, Inc. (41)
MedMen Enterprises, Inc. (4)
Melt Pharmaceuticals, Inc. (1)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (5)
MICROCHANNEL TECHNOLOGIES CORP (5)
MiddleBrook Pharmaceuticals, Inc. (7)
Milestone Pharmaceuticals Inc. (3)
Mind Medicine (MindMed) Inc. (1)
MJ Holdings, Inc. (10)
Molecular Insight Pharmaceuticals, Inc. (2)
Mylan N.V. (2)
MYnd Analytics, Inc. (7)
Nabriva Therapeutics plc (6)
NEKTAR THERAPEUTICS (7)
Neuralstem, Inc. (14)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (10)
NEXIEN BIOPHARMA, INC. (1)
Notis Global, Inc. (28)
NovaBay Pharmaceuticals, Inc. (18)
Novan, Inc. (10)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (6)
NURX PHARMACEUTICALS, INC. (1)
OCULAR THERAPEUTIX, INC (1)
OMEROS CORP (3)
OncoMed Pharmaceuticals Inc (1)
Onconova Therapeutics, Inc. (13)
One World Pharma, Inc. (8)
OPIANT PHARMACEUTICALS, INC. (2)
OptiNose, Inc. (1)
ORAMED PHARMACEUTICALS INC. (14)
OSCIENT PHARMACEUTICALS CORP (2)
Osmotica Pharmaceuticals plc (2)
Panacea Acquisition Corp (6)
PANACOS PHARMACEUTICALS, INC. (1)
Paratek Pharmaceuticals, Inc. (2)
PaxMedica, Inc. (3)
PENWEST PHARMACEUTICALS CO (1)
Perrigo (1)
PetLife Pharmaceuticals, Inc. (2)
Petros Pharmaceuticals, Inc. (4)
Pharmagreen Biotech Inc. (4)
PHARMOS CORP (2)
Phibro Animal Health Corporation (4)
Planet 13 Holdings Inc. (5)
PLAYERS NETWORK (22)
PLx Pharma Inc. (13)
POLYDEX PHARMACEUTICALS LTD (1)
PONIARD PHARMACEUTICALS, INC. (2)
PRAECIS PHARMACEUTICALS INC (1)
Prestige Brands Holdings Inc (4)
PRESTWICK PHARMACEUTICALS INC (1)
Processa Pharmaceuticals, Inc. (9)
ProPhase Labs, Inc. (3)
PROVECTUS BIOPHARMACEUTICALS, INC. (3)
Provention Bio, Inc. (7)
Pulmatrix, Inc. (11)
QUANTA INC (4)
QUESTCOR PHARMACEUTICALS INC (3)
Quoin Pharmaceuticals, Ltd. (9)
RADIENT PHARMACEUTICALS Corp (1)
Rani Therapeutics Holdings, Inc. (2)
Recro Pharma, Inc. (6)
Reliant Pharmaceuticals, Inc. (1)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (24)
ROCK CREEK PHARMACEUTICALS, INC. (4)
Roivant Sciences Ltd. (5)
Royalty Pharma plc (5)
Sagent Pharmaceuticals, Inc. (3)
SALIX PHARMACEUTICALS LTD (2)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (2)
Scopus BioPharma Inc. (3)
scPharmaceuticals Inc. (1)
SCYNEXIS INC (1)
SenesTech, Inc. (11)
SIGA TECHNOLOGIES INC (2)
Sonoma Pharmaceuticals, Inc. (17)
Stem Holdings, Inc. (1)
Sucampo Pharmaceuticals, Inc. (3)
Sunset Island Group (2)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
Supernus Pharmaceuticals, Inc. (8)
SYNERGY PHARMACEUTICALS, INC. (12)
Synovics Pharmaceuticals (1)
TAPESTRY PHARMACEUTICALS, INC (1)
Target Group Inc. (10)
Targeted Medical Pharma, Inc. (4)
TAURIGA SCIENCES, INC. (40)
Tenzing Acquisition Corp. (8)
Terra Tech Corp. (33)
TerrAscend Corp. (4)
TETRALOGIC PHARMACEUTICALS CORP (2)
TETRAPHASE PHARMACEUTICALS INC (3)
Textmunication Holdings, Inc. (15)
TFF Pharmaceuticals, Inc. (6)
The Medicines Company (1)
TherapeuticsMD, Inc. (1)
Theravance Biopharma, Inc. (2)
Tilray, Inc. (2)
TILT Holdings Inc. (1)
TITAN PHARMACEUTICALS INC (13)
Tribute Pharmaceuticals Canada Inc. (7)
Tricida, Inc. (1)
Upjohn Inc (1)
Urigen Pharmaceuticals, Inc. (3)
Urovant Sciences Ltd. (1)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Valera Pharmaceuticals Inc (1)
Vallon Pharmaceuticals, Inc. (9)
VASO ACTIVE PHARMACEUTICALS INC (1)
Ventyx Biosciences, Inc. (2)
Verano Holdings Corp. (4)
VIA Pharmaceuticals, Inc. (3)
Virpax Pharmaceuticals, Inc. (7)
Vitality Biopharma, Inc. (19)
VIVUS INC (7)
WEED, INC. (3)
XANODYNE PHARMACEUTICALS INC (1)
Xeris Biopharma Holdings, Inc. (1)
XERIS PHARMACEUTICALS INC (1)
ZOGENIX, INC. (6)
Zomedica Pharmaceuticals Corp. (7)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Form of Securities Purchase Agreement (Onconova Therapeutics, Inc., Filed With SEC on December 31, 2024)
Securities Purchase Agreement, dated December 29, 2024, by and among KALA BIO, Inc. and the purchasers party thereto (Kala Pharmaceuticals, Inc., Filed With SEC on December 30, 2024)
Form of Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd., Filed With SEC on December 26, 2024)
Form of Amendment to Warrants to Purchase Ordinary Shares Represented by American Depositary Shares (Quoin Pharmaceuticals, Ltd., Filed With SEC on December 26, 2024)
Form of Purchase Agreement (Bespoke Extracts, Inc., Filed With SEC on December 26, 2024)
Securities Purchase Agreement between Cingulate Inc. and Streeterville Capital, LLC, dated December 20, 2024 (Cingulate Inc., Filed With SEC on December 23, 2024)
Form of Securities Purchase Agreement, dated December 23, 2024, by and between the Company and the purchasers listed on the signature page thereto (Anebulo Pharmaceuticals, Inc., Filed With SEC on December 23, 2024)
Purchase Agreement, dated as of December 13, 2024, by and between Adial Pharmaceuticals, Inc. and Alumni Capital LP (ADIAL PHARMACEUTICALS, INC., Filed With SEC on December 18, 2024)
Asset Purchase Agreement, dated December 17, 2024, by and among Cara Therapeutics, Inc. Cara Royalty Sub, LLC and Vifor Fresenius Medical Care Renal Pharma, Ltd (Cara Therapeutics, Inc., Filed With SEC on December 18, 2024)
Form of the Securities Purchase Agreement, dated December 12, 2024, by and between China Pharma Holdings Inc. and the Investor (CHINA PHARMA HOLDINGS, INC., Filed With SEC on December 13, 2024)
Form of Purchase Agreement (Eton Pharmaceuticals, Inc., Filed With SEC on December 12, 2024)
Form of Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd., Filed With SEC on December 11, 2024)
Form of Securities Purchase Agreement, dated December 5, 2024 (EYENOVIA, INC., Filed With SEC on December 9, 2024)
Amendment No. 1 to Purchase and Sale Agreement, by and between the Company and Solaris Bidco Limited, Solaris IPCo Limited and Solaris US BidCo, LLC, dated as of November 29, 2024 (Mallinckrodt, Filed With SEC on December 5, 2024)
Form of Purchase Agreement (Biofrontera Inc., Filed With SEC on November 27, 2024)
Form of Securities Purchase Agreement, dated November 24, 2024 (EYENOVIA, INC., Filed With SEC on November 26, 2024)
Agreement for the Purchase and Sale of Future Receipts with Agile Capital (MYnd Analytics, Inc., Filed With SEC on November 19, 2024)
Form of Securities Purchase Agreement, dated November 18, 2024, by and between the Company and the investors named therein (Aclaris Therapeutics, Inc., Filed With SEC on November 18, 2024)
Form of Securities Purchase Agreement, dated as of November 15, 2024, by and among Citius Pharmaceuticals, Inc. and the investors signatory thereto (Citius Pharmaceuticals, Inc., Filed With SEC on November 18, 2024)
Form of Securities Purchase Agreement (Virpax Pharmaceuticals, Inc., Filed With SEC on November 15, 2024)
Equity Purchase Agreement, dated July 29, 2024, as amended on October 28, 2024, among Verano Arizona, LLC, 203 Organix L.L.C., CC VA HoldCo LLC, Columbia Care-Arizona, Prescott,... (Verano Holdings Corp., Filed With SEC on November 7, 2024)
Amendment, dated October 28, 2024, to Equity Purchase Agreement, dated July 29, 2024, among Verano Arizona, LLC, 203 Organix L.L.C., CC VA HoldCo LLC, Columbia Care-Arizona,... (Columbia Care Inc., Filed With SEC on November 7, 2024)
Amendment No.3 to the Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, effective as of July 31, 2024, by and between Aadi Bioscience, Inc. and... (Aerpio Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Amendment No. 1 to Asset Purchase Agreement, dated as of November 5, 2024, between PRN Physician Recommended Nutriceuticals, LLC and NovaBay Pharmaceuticals, Inc (NovaBay Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Asset Purchase Agreement, dated as of November 1, 2024, between Nektar and Purchaser (NEKTAR THERAPEUTICS, Filed With SEC on November 4, 2024)
Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of October 28, 2024 (Evofem Biosciences, Inc., Filed With SEC on October 28, 2024)
Form of Securities Purchase Agreement (CNS Pharmaceuticals, Inc., Filed With SEC on October 24, 2024)
Form of Securities Purchase Agreement to be entered into in this Offering (Virpax Pharmaceuticals, Inc., Filed With SEC on October 18, 2024)
Form of Securities Purchase Agreement, dated October 15, 2024 (Rani Therapeutics Holdings, Inc., Filed With SEC on October 16, 2024)
Form of Securities Purchase Agreement (Lexaria Bioscience Corp., Filed With SEC on October 16, 2024)
Forward Purchase Agreement dated September 26, 2024 between CanPoland Spółka Akcyjna ,Allied Colombia S.A.S and Blossom Genetics Lda (COSMO VENTURES INC, Filed With SEC on October 15, 2024)
Purchase and Sale Agreement, dated October 8, 2024, by and among Scilex Holding Company, Silex Pharmaceuticals Inc. and the purchasers signatory thereto (ORAMED PHARMACEUTICALS INC., Filed With SEC on October 8, 2024)
Securities Purchase Agreement, dated October 7, 2024, by and between Scilex Holding Company and the investors signatory thereto (ORAMED PHARMACEUTICALS INC., Filed With SEC on October 8, 2024)
Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of October 2, 2024 (Evofem Biosciences, Inc., Filed With SEC on October 3, 2024)
Form of Amendment No. 1 to Securities Purchase Agreement, dated September 30, 2024, by and among Talphera, Inc. and entities affiliated with Nantahala Management, LLC (ACELRX PHARMACEUTICALS INC, Filed With SEC on October 1, 2024)
Form of Securities Purchase Agreement, dated September 26, 2024 (EYENOVIA, INC., Filed With SEC on September 30, 2024)
Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of September 20, 2024 (Evofem Biosciences, Inc., Filed With SEC on September 25, 2024)
Securities Purchase Agreement, dated September 23, 2024, by and between the Company and the Investor (Ventyx Biosciences, Inc., Filed With SEC on September 23, 2024)
Asset Purchase Agreement, dated September 19, 2024, by and between NovaBay Pharmaceuticals, Inc. and PRN Physician Recommended Nutriceuticals, LLC (NovaBay Pharmaceuticals, Inc., Filed With SEC on September 20, 2024)
Form of Securities Purchase Agreement (Dermata Therapeutics, Inc., Filed With SEC on September 17, 2024)